Phase 2 study of neoadjuvant enzalutamide and paclitaxel for luminal androgen receptor-enriched TNBC: Trial results and insights into “ARness” von Lim, Bora, Seth, Sahil, Yam, Clinton, Huo, Lei, Fujii, Takeo, Lee, Jangsoon, Bassett, Roland, Nasser, Sara, Ravenberg, Lisa, White, Jason, Clayborn, Alyson, Guerra, Gil, Litton, Jennifer K., Damodaran, Senthil, Layman, Rachel, Valero, Vicente, Tripathy, Debasish, Lewis, Michael, Dobrolecki, Lacey E., Lei, Jonathan, Candelaria, Rosalind, Arun, Banu, Rauch, Gaiane, Zhao, Li, Zhang, Jianhua, Ding, Qingqing, Symmans, W. Fraser, Chang, Jeffrey T., Thompson, Alastair M., Moulder, Stacy L., Ueno, Naoto T.

Volltext